Therapeutic effects of LS-13 on glioma in vivo and in vitro

CNS Neurosci Ther. 2014 Oct;20(10):947-9. doi: 10.1111/cns.12320. Epub 2014 Aug 28.

Authors

Wei Wang¹, Xiang Xu, Cheng-Yuan Ji, Ling-Yun Wu, Zhong Wang, Gang Chen

Affiliation

¹ Department of Neurosurgery, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.

No abstract available

Publication types

Letter

MeSH terms

Animals
Antineoplastic Agents / chemistry
Antineoplastic Agents / pharmacology
Antineoplastic Agents / therapeutic use*
Brain Neoplasms / drug therapy*
Cell Line, Tumor
Cell Movement / drug effects
Dose-Response Relationship, Drug
Glioma / drug therapy*
Humans
Mice
Mice, Nude
Quinolines / pharmacology
Quinolines / therapeutic use*
Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors
Vascular Endothelial Growth Factor Receptor-3 / antagonists & inhibitors
Xenograft Model Antitumor Assays

Substances

Antineoplastic Agents
LS-13 compound
Quinolines
Receptors, Vascular Endothelial Growth Factor
Vascular Endothelial Growth Factor Receptor-3